Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Beat the Bloat
- Development stage
- Unknown
- Lead developer
- Olly
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Therapeutic Enzymes → Recombinant Proteins and Enzymes, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Beat the Bloat is a multi-ingredient dietary supplement developed by OLLY, designed to support digestive health and alleviate occasional symptoms of bloating and gas. The formulation features a comprehensive blend of digestive enzymes, including amylase, cellulase, hemicellulase, lactase, alpha-galactosidase, and lipase, which assist the body in breaking down complex carbohydrates, lactose, fats, and vegetable fibers. These enzymes are complemented by a botanical blend of dandelion extract (100 mg), ginger extract (50 mg), and fennel extract (100 mg), which are traditionally used for their carminative and digestive-supportive properties. Delivered in a vegetarian capsule format, the product is marketed as a wellness supplement to support the body's natural digestive processes rather than as a pharmaceutical treatment for specific medical conditions.
- Brand names
- Beat the Bloat
- Other names
- OLLY Beat the Bloatdigestive enzymes + dandelion extract + ginger extract + fennel extract
Beyond the preview
Go deeper on Beat the Bloat.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beat the Bloat.